Immunotech Biopharm Tightens Audit Committee Rules to Bolster Governance

Immunotech Biopharm Ltd ( (HK:6978) ) has provided an update.

Immunotech Biopharm Ltd has updated the terms of reference for its audit committee as of 20 March 2026, reaffirming the committee’s role in supporting the board on financial reporting, risk management and internal control, and in maintaining an appropriate relationship with external auditors. The revised framework sets clear requirements on committee composition, meeting frequency, quorum, attendance and voting, emphasizing independent non-executive oversight and stricter auditor-related safeguards, which strengthens the company’s corporate governance and alignment with Hong Kong listing standards.

The audit committee must comprise at least three non-executive directors, with a majority being independent and at least one possessing professional accounting or financial management expertise in line with Listing Rule 3.10(2). The rules also bar former partners of the current audit firm from committee membership for two years, formalize at least two meetings annually, mandate regular interaction with internal and external auditors, and give the committee chairman responsibility for scheduling, agenda setting and reporting, thereby enhancing transparency and control over financial and audit processes.

The most recent analyst rating on (HK:6978) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Immunotech Biopharm Ltd stock, see the HK:6978 Stock Forecast page.

More about Immunotech Biopharm Ltd

Immunotech Biopharm Ltd is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange under stock code 6978. The company operates in the biopharmaceutical sector, and its governance framework follows Hong Kong Listing Rules, with a board structure that includes non-executive and independent non-executive directors to oversee compliance and financial reporting.

Average Trading Volume: 368,440

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.49B

Find detailed analytics on 6978 stock on TipRanks’ Stock Analysis page.